Evidence map›Paper›PMID 25116430›Full record

ArticleThe Journal of comparative neurology2015

Conserved expression of the GPR151 receptor in habenular axonal projections of vertebrates.

Jonas Broms, Beatriz Antolin-Fontes, Anders Tingström, Ines Ibañez-Tallon

Abstract read
In one paragraph

Article in The Journal of comparative neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 52 citations in OpenAlex.

  1. Novel Ligands for the Orphan Receptor GPR151 Modulate Morphine Action.Genes to cells : devoted to molecular & cellular mechanisms · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. The habenular G-protein-coupled receptor 151 regulates synaptic plasticity and nicotine intake.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  19. Article
  20. The Opioid Crisis and the Future of Addiction and Pain Therapeutics.The Journal of pharmacology and experimental therapeutics · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jonas BromsPsychiatric Neuromodulation Unit, Clinical Sciences, Lund University, 222 42, Lund, Sweden.
Beatriz Antolin-Fontes
Anders Tingström
Ines Ibañez-Tallon
Lund University · SERockefeller University · US

Funding

RESEARCH SUPPORT CORE 4P30DA035756 · NIDA · ROCKEFELLER UNIVERSITY · PI HEINTZ, NATHANIEL · 2013 to 2017
$6.7M
NIDA NIH HHS 1P30 DA035756-01NIDA NIH HHS P30 DA035756
6 · The paper itself

Abstract

The habenula is a phylogenetically conserved brain structure in the epithalamus. It is a major node in the information flow between fronto-limbic brain regions and monoaminergic brainstem nuclei, and is thus anatomically and functionally ideally positioned to regulate emotional, motivational, and cognitive behaviors. Consequently, the habenula may be critically important in the pathophysiology of psychiatric disorders such as addiction and depression. Here we investigated the expression pattern of GPR151, a G protein-coupled receptor (GPCR), whose mRNA has been identified as highly and specifically enriched in habenular neurons by in situ hybridization and translating ribosome affinity purification (TRAP). In the present immunohistochemical study we demonstrate a pronounced and highly specific expression of the GPR151 protein in the medial and lateral habenula of rodent brain. Specific expression was also seen in efferent habenular fibers projecting to the interpeduncular nucleus, the rostromedial tegmental area, the rhabdoid nucleus, the mesencephalic raphe nuclei, and the dorsal tegmental nucleus. Using confocal microscopy and quantitative colocalization analysis, we found that GPR151-expressing axons and terminals overlap with cholinergic, substance P-ergic, and glutamatergic markers. Virtually identical expression patterns were observed in rat, mouse, and zebrafish brains. Our data demonstrate that GPR151 is highly conserved, specific for a subdivision of the habenular neurocircuitry, and constitutes a promising novel target for psychiatric drug development.

Indexed as

AnimalsAxonsbeta-GalactosidaseCholine O-AcetyltransferaseHabenulaHumansInterpeduncular NucleusMesencephalonMiceMice, Inbred C57BLMice, KnockoutNerve NetNeurofilament ProteinsNeuronsRatsRats, Wistarbeta-GalactosidaseCholine O-Acetyltransferaseneurofilament protein HNeurofilament ProteinsNpbwr1 protein, mouseReceptors, G-Protein-CoupledReceptors, NeuropeptideSubstance PTryptophan HydroxylaseTyrosine 3-MonooxygenaseVesicular Glutamate Transport ProteinsAB_10123643AB_10608138AB_10743815AB_2079751AB_261587AB_307210AB_477560AB_572266AB_628299AB_887876AB_887878AB_887883AB_887884AB_90754fasciculus retroflexusG protein-coupled receptorinterpeduncular nucleusMGI_MGI:3606630raphe nucleusRGD_737929rhabdoid nucleusrostromedial tegmental nucleusSciRes_000137ZIRC_ZL1

Identifiers

PMID25116430
PMCPMC4270839
OpenAlexW2153700750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.